Friedland, G H <br/><br/>
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Aug 1999 
 - 281-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/00126334-199908010-00005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Delavirdine--administration & dosage<br/>Didanosine--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--drug therapy<br/>HIV-1--isolation & purification<br/>Humans<br/>Male<br/>RNA, Viral--blood<br/>Reverse Transcriptase Inhibitors--administration & dosage<br/>Safety<br/>Zidovudine--administration & dosage